hypercholesterolemia
Increase in Healthcare Utilization, Costs Modest After Genetic Risk Results Return
Researchers tracked follow-up healthcare use and cost in the 12 months after individuals and providers received pathogenic or likely pathogenic variant results for five conditions.
Helix, Nebraska Medicine Partner to Launch Genomic Health-Risk Screening Program
The effort aims to enroll 100,000 people on a voluntary basis, testing genes linked to a higher risk of breast and ovarian cancer, Lynch syndrome, and high cholesterol.
Intermountain Builds Up Bioinformatics to Make HerediGene Sequencing Data Clinically Actionable
Premium
The health system, which has now enrolled 150,000 people in its population genomics program, has implemented its technology across CDC tier one conditions but has grander ambitions.
23andMe Gains FDA Clearance for Simvastatin Pharmacogenetic Report
The new clearance removes the need for confirmatory testing to use 23andMe's SLCO1B1 report before prescribing simvastatin for hyperlipidemia.
Geisinger Researchers Win $7M for Familial Hypercholesterolemia Studies With Genetic Testing
Premium
The funding expands FH research at the health system and supports work using its MyCode community health initiative.